PRTA Prothena Corporation plc

NASDAQ
$7.97

Prothena Corporation plc (PRTA) is expected to report earnings on February 4, 2027, after the market close. The consensus earnings estimate is $0.00 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +1.3% since its last earnings release on November 5, 2026.

Prothena Corporation plc Beat Consensus Estimates
Thursday, November 5, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 4
Thursday · 4:05 PM ET
Earnings Whisper
-
vs $0.00
Rev est $28.02M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $8.41

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Prothena Corporation plc

Prothena Corp PLC is a biotechnology company. It discovers and develops novel antibodies for the potential treatment of a broad range of diseases that involve protein misfolding or cell adhesion.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.